Cargando…
Economic evaluation of the screening for Alzheimer’s disease in China
BACKGROUND: We evaluated the cost-effectiveness of the screening in mainland China for Alzheimer’s disease (AD) patients aged over 60. METHODS: Individuals in mainland China, received an initial screening by questionnaire on mental state, and those with scores deemed suspicious for AD were referred...
Autores principales: | Ren, Yinan, Zhou, Dachuang, Xing, Qian, Gong, Fangfang, Tang, Wenxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553991/ https://www.ncbi.nlm.nih.gov/pubmed/36248004 http://dx.doi.org/10.3389/fnagi.2022.968842 |
Ejemplares similares
-
Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022) -
Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
por: Shao, Taihang, et al.
Publicado: (2022) -
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease
por: Lai, Yongxing, et al.
Publicado: (2022) -
C9orf72 mutation is rare in Alzheimer's disease, Parkinson's disease, and essential tremor in China
por: Jiao, Bin, et al.
Publicado: (2013) -
Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis
por: Zhao, Mingye, et al.
Publicado: (2022)